CN105343704A - Drug for treating migraine - Google Patents
Drug for treating migraine Download PDFInfo
- Publication number
- CN105343704A CN105343704A CN201510796107.6A CN201510796107A CN105343704A CN 105343704 A CN105343704 A CN 105343704A CN 201510796107 A CN201510796107 A CN 201510796107A CN 105343704 A CN105343704 A CN 105343704A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- radix angelicae
- treatment
- migraine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 208000019695 Migraine disease Diseases 0.000 title abstract description 16
- 206010027599 migraine Diseases 0.000 title abstract description 14
- 229940079593 drug Drugs 0.000 title abstract description 7
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 3
- 208000002193 Pain Diseases 0.000 abstract description 7
- 230000036407 pain Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000004087 circulation Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 abstract description 2
- 241000864411 Alangium platanifolium Species 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 241001022083 Flemingia Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 2
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 2
- 240000007049 Juglans regia Species 0.000 abstract 2
- 235000009496 Juglans regia Nutrition 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 235000020234 walnut Nutrition 0.000 abstract 2
- 238000007791 dehumidification Methods 0.000 abstract 1
- 238000001784 detoxification Methods 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000005906 menstruation Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 13
- 231100000869 headache Toxicity 0.000 description 13
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 206010052787 migraine without aura Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 208000005056 Ophthalmoplegic Migraine Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010052784 Retinal migraine Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 210000003208 abducens nerve Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000002109 interictal effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000007896 modified release capsule Substances 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000007939 sustained release tablet Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a drug for treating migraine, and the drug comprises the following raw ingredients by weight: 17 parts of angelica, 11 parts of radix angelicae, 10 parts of walnut kernel, 9 parts of philippine flemingia root, 15 parts of corydalis tuber, 9 parts of rhizoma smilacis glabrae, 10 parts of cortex albiziae, 8 parts of gynostemma and 9 parts of alangium platanifolium. The angelica is used for activating blood to promote menstruation; the radix angelicae is used for opening aperture and relieving pains, the walnut kernel is used for warming and tonifying lung and kidney, the philippine flemingia root is used for is used for dispersing blood stasis and detoxifying, the corydalis tuber is used for activating blood and promoting circulation of qi, the rhizoma smilacis glabrae is used for dehumidification detoxification, the cortex albiziae is used for is used for resolving stagnation for tranquilization, the gynostemma is used for is used for clearing away heat and toxic materials, and the alangium platanifolium is used for dispersing stasis and relieving pains, the various drugs are in combined use to together play the effects of dispelling wind, dispelling cold, opening aperture and relieving pains for effective treatment of migraine. Clinical experiments prove the drug can be safe and effective in the treatment of the migraine.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to one and be used for the treatment of migrainous medicine.
Background technology
Migraine is clinical modal primary headache type; clinical in show effect with middle severe, sample of beating headache for main manifestations; headache mostly is inclined side; general lasting 4 ~ 72 hours; can with Nausea and vomiting; light, Sound stimulat or daily routines all can increase the weight of headache, and quiet environment, rest can alleviate headache.Migraine is a kind of common chronic forms vascular illness, and a lot of disease is in child and adolescence, and the young and middle-aged phase reaches onset peak, and women is common, and men and women's Proportion of patients is about 1: 2 ~ 3, and in crowd, prevalence is 5% ~ 10%, often has genetic background.
Clinical manifestation: 1) Migraine without aura is modal migraines, accounts for 80%.
2) migraine without aura accounts for migraineur's 10%.Before outbreak, can there be asthenia, the absent minded and prodrome such as to yawn a few hours to a few days
3) retinal migraine is the uniocular vision obstacle of the completely reversibility repeatedly occurred, and comprises flicker, dim spot or blind, and accompanies migraine, normal at interictal ophthalmologic examination
4) there is branch hole myoparalysis of having a headache in ophthalmoplegic migraine Headache attacks simultaneously or in 4 days, oculomotorius is the most often got involved, and often has the ptosis, platycoria, and some cases can involve coaster and abducent nerve simultaneously.
Current doctor trained in Western medicine clinical treatment migraine medication multiselect Naproxen Sustained Release Tablet, ibuprofen modified release capsule, Ankahuangmin Tablets, aspirin etc.But cure the symptoms, not the disease more, easily cause Relapse rate to show effect.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide one and is used for the treatment of migrainous medicine, by selecting suitable medical material and proportioning thereof, reaches the migrainous object of safe and effective healing.
In order to achieve the above object, the present invention is by the following technical solutions:
One is used for the treatment of migrainous medicine, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Angelicae Sinensis 17 parts, the Radix Angelicae Dahuricae 11 parts, Semen Juglandis 10 parts, Radix Flemingiae Philippinensis 9 parts, Rhizoma Corydalis 15 parts, Rhizoma Smilacis Glabrae 9 parts, Cortex Albiziae 10 parts, Herb Gynostemmae Pentaphylli 8 parts, Radix Alangii 9 parts.
Inventor thinks: the cause of disease such as wind and cold or blood stasis is dragged for a long time and do not controlled, and pathogenic factor invades passages through which vital energy circulates and to deposit obstructed one-tenth disease.Manner is unclear, and wind and cold is not loose is disease close to home.Expelling wind and cold, removing obstruction in the collateral to relieve pain should be noted during treatment.
The present invention uses: Radix Angelicae Sinensis promoting blood circulation to restore menstrual flow; Radix Angelicae Dahuricae understand things pain-stopping; Semen Juglandis temperature compensation lung kidney; Radix Flemingiae Philippinensis repercussive detoxifies; Rhizoma Corydalis is invigorated blood circulation promoting the circulation of QI; Rhizoma Smilacis Glabrae removing dampness and detoxicating; Cortex Albiziae resolving stagnation for tranquilization; Herb Gynostemmae Pentaphylli heat-clearing and toxic substances removing; The pain relieving of Radix Alangii scattered silt.All medicines share, and effect of long memorial wind, dissipating cold, removing obstruction in the collateral to relieve pain, effectively treats migraine altogether.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, physical data
Inventor collects migraineur 70 example for 2012 altogether between year December of December ~ 2014, all from Neurology Clinic, and 35 ~ 50 years old age, male 25 example, women 45 example.The course of disease 1 year ~ 8 years.
Diagnostic criteria: according to the diagnostic criteria of ICHD2 migraine
Do you feel sick and (are sick in the stomach during headache or stomach discomfort?), work capacity decline (nearest March have at least one sky because of headache limitation of activity?) and photophobia (be subject to light during headache to bother?).If answered certainly according to three problems 2, then migrainous positive predictive value is 93%, if 3 problems are all answered certainly, its positive predictive value reaches 98%.
Meet above-mentioned diagnostic criteria, the patient that the age is greater than 18 years old.
Exclusion standard: trimester of pregnancy, women breast-feeding their children; Merge serious cardiopulmonary hepatorenal disease person.
2, test method
The decoct that the oral the present invention of all patients obtains according to embodiment 1, every day 3 times.4 weeks courses for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Judge according to " migraine disease diagnosis and efficacy assessment standard ".
1. effective: patient's Headache attacks disappears or the number of times of clinical episodes reduces >75%
2. effective: the degree of patient's headache alleviates gradually and the number of times of clinical episodes reduces to 50% ~ 75%;
3. invalid: the number of times of patient's Headache attacks has reduced <50% or clinical symptoms is unchanged
3.2 therapeutic outcome
Effective 54 examples of 70 routine patients, effective 12 examples, invalid 4 examples, total effective rate 94%.There is laxativeness in treatments period 2 example, has no other obvious adverse reaction.It is safe and effective that visible the present invention is used for the treatment of migraine, has the value applied.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Radix Angelicae Sinensis 17 grams, the Radix Angelicae Dahuricae 11 grams, Semen Juglandis 10 grams, Radix Flemingiae Philippinensis 9 grams, Rhizoma Corydalis 15 grams, Rhizoma Smilacis Glabrae 9 grams, Cortex Albiziae 10 grams, Herb Gynostemmae Pentaphylli 8 grams, Radix Alangii 9 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of migraine.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Radix Angelicae Sinensis 17 grams, the Radix Angelicae Dahuricae 11 grams, Semen Juglandis 10 grams, Radix Flemingiae Philippinensis 9 grams, Rhizoma Corydalis 15 grams, Rhizoma Smilacis Glabrae 9 grams, Cortex Albiziae 10 grams, Herb Gynostemmae Pentaphylli 8 grams, Radix Alangii 9 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of migraine.Oral, daily once.
Embodiment 3
Take: Radix Angelicae Sinensis 17 grams, the Radix Angelicae Dahuricae 11 grams, Semen Juglandis 10 grams, Radix Flemingiae Philippinensis 9 grams, Rhizoma Corydalis 15 grams, Rhizoma Smilacis Glabrae 9 grams, Cortex Albiziae 10 grams, Herb Gynostemmae Pentaphylli 8 grams, Radix Alangii 9 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of migraine.Oral, every bu is taken for twice sooner or later.
Claims (4)
1. one kind is used for the treatment of migrainous medicine, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Radix Angelicae Sinensis 17 parts, the Radix Angelicae Dahuricae 11 parts, Semen Juglandis 10 parts, Radix Flemingiae Philippinensis 9 parts, Rhizoma Corydalis 15 parts, Rhizoma Smilacis Glabrae 9 parts, Cortex Albiziae 10 parts, Herb Gynostemmae Pentaphylli 8 parts, Radix Alangii 9 parts.
2. be used for the treatment of migrainous medicine as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 17 parts, the Radix Angelicae Dahuricae 11 parts, Semen Juglandis 10 parts, Radix Flemingiae Philippinensis 9 parts, Rhizoma Corydalis 15 parts, Rhizoma Smilacis Glabrae 9 parts, Cortex Albiziae 10 parts, Herb Gynostemmae Pentaphylli 8 parts, Radix Alangii 9 parts; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 parts, obtains decoct; Above-mentioned part all refers to weight portion.
3. be used for the treatment of migrainous medicine as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 17 parts, the Radix Angelicae Dahuricae 11 parts, Semen Juglandis 10 parts, Radix Flemingiae Philippinensis 9 parts, Rhizoma Corydalis 15 parts, Rhizoma Smilacis Glabrae 9 parts, Cortex Albiziae 10 parts, Herb Gynostemmae Pentaphylli 8 parts, Radix Alangii 9 parts; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, obtains powder; Above-mentioned part all refers to weight portion.
4. be used for the treatment of migrainous medicine as claimed in claim 1, it is characterized in that, its preparation method is: take: Radix Angelicae Sinensis 17 parts, the Radix Angelicae Dahuricae 11 parts, Semen Juglandis 10 parts, Radix Flemingiae Philippinensis 9 parts, Rhizoma Corydalis 15 parts, Rhizoma Smilacis Glabrae 9 parts, Cortex Albiziae 10 parts, Herb Gynostemmae Pentaphylli 8 parts, Radix Alangii 9 parts; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, obtains capsule; Above-mentioned part all refers to weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510796107.6A CN105343704A (en) | 2015-11-18 | 2015-11-18 | Drug for treating migraine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510796107.6A CN105343704A (en) | 2015-11-18 | 2015-11-18 | Drug for treating migraine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105343704A true CN105343704A (en) | 2016-02-24 |
Family
ID=55319863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510796107.6A Pending CN105343704A (en) | 2015-11-18 | 2015-11-18 | Drug for treating migraine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105343704A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104721591A (en) * | 2015-04-01 | 2015-06-24 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating migraine |
| CN105031303A (en) * | 2015-07-01 | 2015-11-11 | 路贝贝 | Drug for treating migraine |
-
2015
- 2015-11-18 CN CN201510796107.6A patent/CN105343704A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104721591A (en) * | 2015-04-01 | 2015-06-24 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating migraine |
| CN105031303A (en) * | 2015-07-01 | 2015-11-11 | 路贝贝 | Drug for treating migraine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101757333A (en) | External traditional Chinese medicament preparation for treating arthralgia | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN101559203B (en) | Chinese medicament preparation for treating angina pectoris | |
| CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
| CN102793903B (en) | Preparation method of Chinese medicament for treating kidney-yang deficiency type acute glomerulonephritis | |
| CN102813757B (en) | Preparation method of traditional Chinese medicine for treating lumbago type acute glomerulonephritis | |
| CN102813837B (en) | Preparation method of traditional Chinese medicine for treating blood pressure rising type acute glomerulonephritis | |
| CN102824421B (en) | Method for preparing Chinese medicinal lotion for treating surprised type closed fracture | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN105343704A (en) | Drug for treating migraine | |
| CN105267321A (en) | Medicine for treating gouty arthritis | |
| CN105232913A (en) | Medicine for treating systemic lupus erythematosus | |
| CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
| CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
| CN103893480A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility | |
| CN103463340A (en) | Traditional Chinese medicine preparation for treating hemicrania | |
| CN102579623A (en) | Preparation method of Chinese lotion for treating traumatic type ecthyma | |
| CN102274336B (en) | Medicine composition for treating rheumatoid arthritis | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
| CN102813822B (en) | Preparation method of traditional Chinese medicine for treating pain type acute glomerulonephritis | |
| CN102813785B (en) | Preparation method of traditional Chinese medicine for treating headache-type acute glomerulonephritis | |
| CN102614456B (en) | Preparation method of traditional Chinese medicine lotion for treating night-sweat-type ecthyma | |
| CN101890076B (en) | Traditional Chinese medicine oral preparation for treating sores and ulcers | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN104984040A (en) | Medicine for treating phthisic hemoptysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160224 |
|
| WD01 | Invention patent application deemed withdrawn after publication |